Lactiga Secures NIH Funding for Groundbreaking Antibody Therapy in IBD Treatment Lactiga US, Inc. has received an NIH grant to develop a unique breastmilk-derived antibody targeting inflammatory bowel disease, aiming to improve treatment outcomes.

Lactiga Secures NIH Funding for Groundbreaking Antibody Therapy in IBD Treatment #USA #Inc. #Inflammatory_Bowel_Disease #North_Brunswick #Lactiga_US #sIgA_antibody

Kenox Pharmaceuticals and Lactiga Forge Strategic Alliance for Immunotherapy Advancement Kenox Pharmaceuticals and Lactiga US have launched a strategic collaboration, focusing on mucosal-targeted immunotherapy to aid immunodeficient patients.

Kenox Pharmaceuticals and Lactiga Forge Strategic Alliance for Immunotherapy Advancement #USA #Princeton #Kenox_Pharmaceuticals #Lactiga_US #mucosal_therapy